New hope for breast cancer patients: drug combo targets remaining disease after chemo
NCT ID NCT07400523
First seen Feb 10, 2026 · Last updated May 01, 2026 · Updated 9 times
Summary
This study tests whether adding ribociclib to standard hormone therapy helps prevent breast cancer from returning in people with hormone receptor-positive, HER2-negative early breast cancer who still have cancer cells after chemotherapy. About 446 participants will be randomly assigned to receive either the combination or hormone therapy alone. The goal is to see if the combination improves how long people live without their cancer coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Guangdong Medical University
RECRUITINGZhanjiang, Guangdong, 524000, China
Contact Phone: •••-•••-••••
-
Shantou Central Hospital
RECRUITINGShantou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sun Yat-sen Memorial Hospital
RECRUITINGGuangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
the First Affiliated Hospital of Guangzhou Medical University
RECRUITINGGuangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.